课题基金 / 基金详情

Apolipoprotein B and associated proteins in the etiology of Alzheimer's disease: A Tau-specific association with Alzheimer pathophysiology.

Apolipoprotein B and associated proteins in the etiology of Alzheimer's disease: A Tau-specific association with Alzheimer pathophysiology.
阿尔茨海默病病因中的载脂蛋白 B 和相关蛋白：与阿尔茨海默病病理生理学的 Tau 特异性关联。
批准号：
444020
负责人：
Poirier Judes
金额：
$73.56万
依托单位：
CIUSSS de l'Ouest-de-l'Ile-de-Montral-Douglas Hospital
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2021
资助国家：
加拿大
项目状态：
未结题
起止时间：
2021-04-01 至 2026-04-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=444020&lang=en
关键词：
Alzheimer'S Disease Apolipoproteins Biomarkers Genetics Pathophysiology Tau Protein

项目摘要

项目成果

Poirier Judes的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The brain changes associated with Alzheimer's disease (AD) begin several years if not decades before the onset of cognitive changes. There is currently no prevention and no cure for the disease. The proposed study will use resources from the Centre for St
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of HMG CoA reductase protective and risk variants in the pathophysiology and treatment of sporadic Alzheimer's disease
Molecular and Biological Characterisation of Novel Genetic Markers Associated to the Common of Alzheimer's Disease in a Population Isolate from Eastern Canada
HMG-CoA reductase in Alzheimer's Disease: Identification of a novel protective variant and unique polymorphisms that modulate Alzheimer pathophysiology.
海外基金